Dysport the newest wrinkle-stopping drug to hit market

May 13, 2009 By Jodi Mailander Farrell

There's a new wrinkle remover on the market. Late last month, the U.S. Food and Drug Administration sanctioned Dysport for cosmetic and therapeutic use. Like Botox, it's an injectable drug derived from a botulinum toxin. It has been sold in Europe at a price cheaper than Botox for several years.

Despite recent FDA warnings that these products could spread beyond the injection site and lead to botulism poisoning, nearly 2.5 million Americans had Botox injections in 2008 for cosmetic reasons. Here's what you need to know before your next dermatologist's visit:

When available: The companies that develop and license Dysport say they plan to make it available in the United States within 60 days.

What is it? Injectable botulinum toxins are purified forms of the bacterial poison that causes botulism, a paralyzing disease that can be fatal. The drugs temporarily reduce or halt .

Warnings: A day after approving Dysport, the FDA issued an order that Dysport and Botox must now carry the most stringent kind of warning labels that explain the material has the potential to spread from the injection site to distant parts of the body -- with the risk of serious difficulties, like problems with swallowing or breathing. Requiring a drug to carry a box with bold-face risk information -- a so-called black-box warning -- is one of the strongest safety actions the FDA can take. It's usually reserved for medications known to have serious or life-threatening risks, such as antidepressants.

Is it safe? The FDA began its safety review of botulinum-based products after being petitioned by the public advocacy group Public Citizen. The group says there have been 180 serious health problems and 16 deaths connected to the injections. But an FDA official in a press conference last month said the problems have occurred mainly in patients who received overdoses of the drug for unapproved treatments, like limb spasticity in children with cerebral palsy. Botulinum toxins are safe when administered for approved uses at approved doses, the FDA says.

Accepted uses: In the last 20 years, the FDA has approved Botox to treat crossed eyes, eyelid spasms, severe underarm sweating, and cervical dystonia, a neck problem that can cause severe pain and abnormal head position. Under the name Botox Cosmetic, the drug is also approved to treat frown lines. The agency recently approved Dysport for frown lines and cervical dystonia.

More info: Read about the FDA's ongoing safety review at www.fda.gov/cder/drug/earlycom… niumtoxins200904.htm .

___

(c) 2009, The Miami Herald.
Visit The Miami Herald Web edition on the World Wide Web at www.herald.com/
Distributed by McClatchy-Tribune Information Services.

Explore further: Feds vows to publicize vaccine injury help program

add to favorites email to friend print save as pdf

Related Stories

FDA warns of botulism with unapproved use of Botox

Apr 30, 2009

(AP) -- Health officials warned doctors and patients Thursday about potentially deadly risks of using the anti-wrinkle drug Botox and similar drugs for unapproved uses to treat certain types of muscle spasms.

FDA acts against unapproved colchicine

Feb 06, 2008

The U.S. Food and Drug Administration said it will take action against companies marketing unapproved injectable colchicine, a drug used to treat gout.

FDA approves skin cancer drug

Oct 13, 2006

The U.S. Food and Drug Administration approved a new drug to treat a rare, slow-growing skin cancer.

FDA issues bismacine-chromacine warning

Jul 24, 2006

The U.S. Food and Drug Administration is warning consumers and healthcare providers not to use a product called bismacine, also known as chromacine.

Recommended for you

US approves new, hard-to-abuse hydrocodone pill (Update)

Nov 20, 2014

U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking ...

Soaring generic drug prices draw Senate scrutiny

Nov 20, 2014

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

Only half of patients take their medications as prescribed

Nov 20, 2014

The cost of patients not taking their medications as prescribed can be substantial in terms of their health. Although a large amount of research evidence has tried to address this problem, there are no well-established ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.